PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
0.00 - 0.01
0.00 - 0.02
289 / 496.9K (Avg.)
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
28.15%
Revenue growth above 1.5x ECL.AX's 8.46%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
27.22%
Gross profit growth above 1.5x ECL.AX's 11.09%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
334.31%
Positive EBIT growth while ECL.AX is negative. John Neff might see a substantial edge in operational management.
334.31%
Positive operating income growth while ECL.AX is negative. John Neff might view this as a competitive edge in operations.
2587.67%
Positive net income growth while ECL.AX is negative. John Neff might see a big relative performance advantage.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-35.50%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-18.95%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
No Data
No Data available this quarter, please select a different quarter.
-76.36%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-78.87%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
-73.52%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
-53.52%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
8.11%
Positive 3Y CAGR while ECL.AX is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
112.96%
Positive long-term OCF/share growth while ECL.AX is negative. John Neff would see a structural advantage in sustained cash generation.
374.44%
Positive OCF/share growth while ECL.AX is negative. John Neff might see a comparative advantage in operational cash viability.
298.40%
3Y OCF/share CAGR above 1.5x ECL.AX's 167.57%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
124.44%
Positive 10Y CAGR while ECL.AX is negative. John Neff might see a substantial advantage in bottom-line trajectory.
130.79%
Positive 5Y CAGR while ECL.AX is negative. John Neff might view this as a strong mid-term relative advantage.
183.33%
Positive short-term CAGR while ECL.AX is negative. John Neff would see a clear advantage in near-term profit trajectory.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
4378.96%
Positive short-term equity growth while ECL.AX is negative. John Neff sees a strong advantage in near-term net worth buildup.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
165.91%
AR growth well above ECL.AX's 23.67%. Michael Burry fears inflated revenue or higher default risk in the near future.
6.12%
We show growth while ECL.AX is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
12.43%
Asset growth above 1.5x ECL.AX's 0.90%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
116.00%
BV/share growth above 1.5x ECL.AX's 1.13%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-45.25%
We’re deleveraging while ECL.AX stands at 0.00%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
-50.01%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
6.62%
SG&A growth well above ECL.AX's 2.22%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.